why AbCellera Biologics Inc [ABCL] is a Good Choice for Investors After New Price Target of $8.33
AbCellera Biologics Inc [NASDAQ: ABCL] traded at a high on 2025-07-09, posting a 8.48 gain after which it closed the day’ session at $4.22. The results of the trading session contributed to over 6972127 shares changing hands. Over the past one week, the price volatility